Treatment & control of benign prostatic hyperplasia (BPH) to cause regression of enlarged prostate, improve urinary flow & symptoms associated w/ BPH. Prevention of urologic events to reduce risk of acute urinary retention & surgery including transurethral resection of prostate & prostatectomy.
Monitor patients w/ large residual urine vol &/or severely diminished urinary flow for obstructive uropathy. Perform digital rectal exam, serum prostate-specific antigen level & other evaluations for prostate cancer. Exclude urethral stricture, infection, cancer, hypotonic bladder & other neurogenic disorders prior to treatment. Changes in breast tissue; male breast cancer. Hepatic dysfunction. Not to be used in women & childn. Elderly >70 yr.